RxSight (RXST) EBT Margin Growth (1y) (2021 - 2026)
RxSight (RXST) EBT Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | -719.00 |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 687.00 |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 458.00 |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 88.00 |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 374.00 |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | 343.00 |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 84.00 |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | -126.00 |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 165.00 |
| 10 | RxSight | 247.91 Mn | -156.34 Mn | - | -65.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -65.00 |
| Mar 31, 2026 | -2,983.00 |
| Dec 31, 2025 | -1,332.00 |
| Sep 30, 2025 | -1,441.00 |
| Jun 30, 2025 | -1,756.00 |
| Mar 31, 2025 | 924.00 |
| Dec 31, 2024 | -15,258.00 |
| Sep 30, 2024 | 3,796.00 |
| Jun 30, 2024 | 4,883.00 |
| Mar 31, 2024 | 4,474.00 |
| Dec 31, 2023 | -18,007.00 |
| Sep 30, 2023 | 7,745.00 |
| Jun 30, 2023 | 8,108.00 |
| Mar 31, 2023 | 12,119.00 |
| Dec 31, 2022 | 50,462.00 |
| Sep 30, 2022 | 8,578.00 |
| Jun 30, 2022 | 12,786.00 |
| Mar 31, 2022 | -161.00 |
| Dec 31, 2021 | -20,028.00 |
| Sep 30, 2021 | -95,464.00 |